1,25-dihydroxyvitamin D3 induces a Th2 immune response in non-obese diabetic mice immunized with GAD65 (524-543).

被引：0
|
作者：
Mathieu, C
Overbergh, L
Casteels, KM
Rutgeerts, O
Waer, M
机构：
[1] Catholic Univ Louvain, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium
[2] Catholic Univ Louvain, Lab Expt Transplantat, B-3000 Louvain, Belgium
来源：
DIABETOLOGIA | 1998年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
244
引用
收藏
页码：A63 / A63
页数：1
相关论文
共 16 条
  • [1] 1α,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543)
    Overbergh, L
    Decallonne, B
    Waer, M
    Rutgeerts, O
    Valckx, D
    Casteels, KM
    Laureys, J
    Bouillon, R
    Mathieu, C
    DIABETES, 2000, 49 (08) : 1301 - 1307
  • [2] T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543)
    Quinn, A
    Sercarz, EE
    JOURNAL OF AUTOIMMUNITY, 1996, 9 (03) : 365 - 370
  • [3] 1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes
    Casteels, K
    Waer, M
    Bouillon, R
    Depovere, J
    Valckx, D
    Laureys, J
    Mathieu, C
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 112 (02): : 181 - 187
  • [4] Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and couticosteroids on TH1, but not TH2, responses
    Jirapongsananuruk, O
    Melamed, I
    Leung, DYM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (05) : 981 - 985
  • [5] 1α,25-dihydroxyvitamin D3 restores thymocyte apoptosis sensitivity in non-obese diabetic (NOD) mice through dendritic cells
    Decallonne, B
    van Etten, E
    Overbergh, L
    Valckx, D
    Bouillon, R
    Mathieu, C
    JOURNAL OF AUTOIMMUNITY, 2005, 24 (04) : 281 - 289
  • [6] Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D3 and 1alpha-hydroxyvitamin D3 on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet
    Driver, J. P.
    Foreman, O.
    Mathieu, C.
    van Etten, E.
    Serreze, D. V.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 151 (01): : 76 - 85
  • [7] IMMUNOMODULATORY EFFECTS OF 1,25-DIHYDROXYVITAMIN D3 ON TH1/TH2 CYTOKINES IN INFLAMMATORY BOWEL DISEASE: AN IN VITRO STUDY
    Ardizzone, S.
    Cassinotti, A.
    Trabattoni, D.
    Manzionna, G.
    Rainone, V.
    Bevilacqua, M.
    Massari, A.
    Manes, G.
    Maconi, G.
    Clerici, M.
    Porro, G. Bianchi
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (01): : 63 - 71
  • [8] 2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D3 protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia
    Kiekhaefer, C. M.
    Weber, B.
    Huggins, M.
    Gorichanaz, C.
    Nehring, J. A.
    DeLuca, H. F.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 166 (03): : 325 - 332
  • [9] Immunomodulating therapy in experimental colitis.: Th1/Th2-switch by 1,25-dihydroxyvitamin D3 in corticosteroid-treated mice
    Daniel, C
    Radeke, H
    Stein, JM
    GASTROENTEROLOGY, 2005, 128 (04) : A199 - A199
  • [10] Effect of Combination Therapy with Angiotensin Receptor Blocker and 1,25-Dihydroxyvitamin D3 in Type 2 Diabetic Nephropathy in KK-Ay/Ta Mice
    Ohara, Ikko
    Tanimoto, Mitsuo
    Gohda, Tomohito
    Yamazaki, Takahiko
    Hagiwara, Shinji
    Murakoshi, Maki
    Aoki, Tatsuya
    Toyoda, Hitoe
    Ishikawa, Yuji
    Funabiki, Kazuhiko
    Horikoshi, Satoshi
    Tomino, Yasuhiko
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2011, 117 (04): : E124 - E132
12